Advanced data platform Relation’s use of single-cell and multi-omics data combined with machine learning signals a clear sales angle for scalable data infrastructure and ML operations. Propose offering an enterprise data platform, cloud compute, data integration services, and scalable analytics pipelines tailored for high-resolution biology to accelerate target discovery and translational research.

Integrated collaborations Relation may benefit from strategic collaborations that complement its internal capabilities with external lab automation, sequencing, and data services. Opportunities include platform licensing, CRO/CDMO partnerships, and joint development agreements to de-risk and accelerate preclinical programs.

Reproducible workflows Relation already values reproducible research with Snakemake and continuous delivery. This aligns with opportunities to provide governance-heavy workflow automation, version-controlled pipelines, security, and compliant data sharing to streamline preclinical studies and regulatory readiness.

Regional expansion Being London-based positions Relation to capitalize on European biopharma ecosystems. Potential sales angles include regulatory and data-management services, EU funding program support, and partnerships to scale operations across Europe.

Mid-market value With a mid-sized team and substantial revenue, Relation may allocate budget for scalable tools, training, and long-term partnerships. Value-based licensing, tiered service levels, and multi-year contracts could fit their growth trajectory and risk profile.